Concepedia

Publication | Closed Access

Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway

57

Citations

12

References

2020

Year

References

YearCitations

Page 1